Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
At the Mercy of Big Pharma
Just over a year ago, President Trump signed an executive order titled “Delivering Most-Favored Nation Prescription Drug Pricing to American Patients.” The aim of the order is to reduce the cost of prescription drugs by linking U.S.
NervGen Pharma Shares Continue Sliding on Size of $60 Million Share Sale
Shares of NervGen Pharma continued to decline after the company specified that it would offer $60 million worth of shares in an upcoming sale. Shares were trading down 42% at $2.14 as of midday Friday. The stock has plunged 62% this year. The…
Letter: Congress must codify drug price reform to rein in Big Pharma
You have permission to edit this article. Get up-to-the-minute news sent straight to your device.
Aurobindo Pharma to expand manufacture of generic formulations in France
Agile Pharma BV, a wholly-owned step-down subsidiary of Aurobindo Pharma, has incorporated a new wholly-owned subsidiary in France, Arrow Pharma Production SAS. Agile Pharma is the holding company of Arrow Pharma Production SAS. As Agile is a…
Torrent Pharma reports 26% decline in net profit
Torrent Pharmaceuticals Limited reported a 26 per cent year-on-year decline in consolidated net profit for the fourth quarter of FY26, weighed down by acquisition-related expenses and severance compensation linked to the integration of JB Chemicals…
Sun Pharma Q4 net profit up 26 per cent
Sun Pharmaceutical Industries Limited expects its research spending to be about 6 to 7 per cent of sales for the financial year 2027, Dilip Shanghvi, Sun Pharma's founder and Executive Chairman said, after the company had announced its financial…
After early Semaglutide lead, Torrent Pharma eyes US liver drug Resmetirom for India launch
After an early lead in Semaglutide generics, Torrent Pharmaceuticals is now positioning itself for what could be a more differentiated play—bringing the US-approved liver disease drug Resmetirom to India once patent barriers ease. Managing…
Sun Pharma Q4 net profit up 26% at ₹2,714 crore
Sun Pharmaceutical Industries Ltd said it clocked a 26.2 per cent growth in net profit, at ₹2,714 crore, for the fourth quarter ended March 31, 2026. The drugmaker's sales for the fourth quarter stood at ₹14,559 crore, up 13.6 per…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1622 GMT – A free trade agreement between the U.K. and the Gulf Cooperation Council countries, a bloc…
Stock markets rebound led by banks, positive global trends
Stock market benchmark indices ended higher on Friday (May 22, 2026), helped by buying in blue-chip bank shares and a rally in global peers. Hopes of progress in the U.S.-Iran peace negotiations also added to markets' optimism. The 30-share BSE…
Indian Stock Market Rebounds: Banks Drive Gains Amid Positive Global Cues
Indian stock market benchmark indices, Sensex and Nifty, rebounded strongly, closing higher on Friday, primarily driven by robust buying in blue-chip banking shares and an overall positive sentiment from global markets. Indian benchmark indices…
The Most Important Healthcare Stock You're Not Watching
A company with a $140 billion market cap is very large. It is also highly likely to be an important player in the industry where it competes. But that doesn't seem to matter today for Pfizer (PFE 0.19%). The healthcare giant's stock has lost more…
Opinion: AbbVie Is the Best Dividend King to Buy in an Increasingly Uncertain Market
Let's face it: We live in uncertain times. There's no clear end in sight to the war with Iran. Fuel prices seem likely to remain elevated for a while, likely pushing the costs of a wide range of products higher. Artificial intelligence (AI) is…
Camden Property Trust: An Investment-Grade Apartment REIT Betting On Sunbelt Growth (NYSE:CPT)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Escaping The Counterfeiting Trap Brands Keep Falling Into
Padmakumar Nair, CEO & Cofounder of Ennoventure Inc. I was in consumer electronics when I first realized something obvious, yet few were talking about it: Blatant fakes were getting through. They were the wrong font weights. They had missing…
Receive a Daily briefing on Pharma Industry News
Get Started